Schwartzkopff B, Hennersdorf M
Abteilung für Kardiologie, Pneumologie und Angiologie, Heinrich Heine Universität, Düsseldorf.
Zentralbl Chir. 2005 Jun;130(3):218-22. doi: 10.1055/s-2005-836555.
Perfusion of the abdomen is determined by cardiac function and circulation. Intestinal ischemia can be caused by Non occlusive bowel ischemia (NOD) that is important in internal as well as surgical intensive care medicine. Cardiac medication can influence perfusion of the bowel: 1) digitalis increases muscular tonus and decreases perfusion regulation b) diuretics lead to hypovolemia, hypotonia and malperfusion, c) antihypertensive medication can cause intraoperative hypotension that demands catecholamines, d) catecholamines can reduce perfusion by pathologic vasoconstriction in the splanchnicus area. Preoperative medication should respect 1) preoperatively taken ACE-inhibitors should be given postoperatively, as they have protective influence on the microcirculation of the bowel, 2) beta-blockers stabilize the myogenic tonus of the abdominal vessels, reduce an overshot of the parasympatheticus and diminish the risk of neurogenic abdominal shock, 3) catecholamines should be used with respect to ischemia of the bowel. Therapy of NOD should be focused on the primary vascular and hemodynamic causes and also take care for bacterial translocation and consecutive sepsis.
腹部灌注取决于心脏功能和循环。肠道缺血可由非闭塞性肠缺血(NOD)引起,这在内科和外科重症医学中都很重要。心脏药物可影响肠道灌注:1)洋地黄增加肌肉张力并降低灌注调节;2)利尿剂导致血容量减少、张力降低和灌注不良;3)抗高血压药物可导致术中低血压,需要使用儿茶酚胺;4)儿茶酚胺可通过内脏区域的病理性血管收缩减少灌注。术前用药应注意:1)术前服用的血管紧张素转换酶抑制剂(ACE抑制剂)术后应继续使用,因为它们对肠道微循环有保护作用;2)β受体阻滞剂可稳定腹部血管的肌源性张力,减少副交感神经亢进,降低神经源性腹部休克的风险;3)使用儿茶酚胺时应考虑肠道缺血情况。NOD的治疗应侧重于主要的血管和血流动力学原因,同时注意细菌移位和继发性脓毒症。